Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
PARK DENTAL PARTNERS INC (PARK)
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-11-04
$20.14-5.67%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
1.58 → 1.58 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for PARK yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
EPS grows to about $1.52 in fiscal 2026 | Earnings per share rise to about $1.52 this year. | Improving | EPS falls below $1.50 in FY26 | Diluted EPS: $0.22 per share FY2026-Q2; GAAP. Published target: >= $1.52. Annual target cannot be compared with a quarterly or TTM observation. Aug 13, 20260.22 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
PARK is a growth-through-acquisitions business with a cyclical risk profile, rather than a proven steady compounder. Its long-term thesis is still insufficiently established because the available history does not support a clear read on recent financial performance.
The valuation evidence labels PARK cheap versus peers, while also showing that its valuation rose recently. There is no evidence of high fragility in what is priced in, but the expectations gap is hard to judge with medium model confidence and limited performance history.
Near term, revenue has grown, management has maintained its fiscal 2026 outlook, and patient visits have increased. Acquisitions and doctor growth support expansion, though recruiting capacity and acquisition execution remain mixed, and the company has a history of a deep miss.
The multi-year thesis depends on PARK maintaining its revenue outlook and turning acquisitions, geographic expansion, and added clinical capacity into continued growth. Near term, a guidance cut or further weakening in jobs data would add pressure, while continued strength and higher guidance from healthcare peers would support the sector backdrop.
Over the next 1 to 3 years, PARK has evidence of revenue growth and active expansion, but the thesis remains uncertain given elevated risk and limited performance history. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Park Dental Partners keeps its revenue near $256 million in 2026. |
| Intact |
| Other revenue falls below $21 million in FY26 |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain fiscal 2026 revenue near $256 million | Park Dental Partners keeps its revenue near $256 million in 2026. | Intact | Annual revenue falls below $254 million in FY26 | Revenue: $66.212M FY2026-Q2; GAAP. Published target: ~$256 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 13, 202666,212,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “ Our revised outlook reflects continued confidence in the underlying performance of our affiliated practices, including patient demand, same-practice revenue growth, provider recruitment, and operational execution.” “ Our updated outlook does not contemplate the recently announced acquisition of Village Family Dental DSO, which remains subject to customary closing conditions and is expected to close later this year.” Delivery assessment Nov 4, 2026 |
Maintain low P/E ratio near 6.0 versus peer median 21.5 | The company trades at a low price-to-earnings ratio of 6.03, much cheaper than peers at 21.49. | Broken | P/E ratio rises above 15, reducing valuation advantage | Valuation inputs unavailable A completed valuation measurement is required. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.96 → $1.58 · observed estimates
$0.27B → $0.30B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.96 | $273,450,000 | 1 / 1 |
| 2026-07-25 | $0.96 | $273,450,000 | 1 / 1 |
| 2026-07-26 | $0.96 | $273,450,000 | 1 / 1 |
| 2026-07-27 | $0.96 | $273,450,000 | 1 / 1 |
| 2026-07-28 | $0.96 | $273,450,000 | 1 / 1 |
| 2026-07-29 | $1.57 | $273,461,500 | 2 / 2 |
| 2026-07-30 | $1.57 | $273,461,500 | 2 / 2 |
| 2026-07-31 | $0.96 | $273,450,000 | 1 / 1 |
| 2026-08-01 | $0.96 | $273,450,000 | 1 / 1 |
| 2026-08-02 | $1.57 | $273,461,500 | 2 / 2 |
| 2026-08-03 | $0.96 | $273,450,000 | 1 / 1 |
| 2026-08-04 | $0.96 | $273,450,000 | 1 / 1 |
| 2026-08-05 | $1.57 | $273,461,500 | 2 / 2 |
| 2026-08-06 | $1.57 | $273,461,500 | 2 / 2 |
| 2026-08-07 | $0.96 | $273,450,000 | 1 / 1 |
| 2026-08-08 | $1.57 | $273,461,500 | 2 / 2 |
| 2026-08-09 | $1.57 | $273,461,500 | 2 / 2 |
| 2026-08-10 | $1.57 | $273,461,500 | 2 / 2 |
| 2026-08-12 | $1.57 | $273,461,500 | 2 / 2 |
| 2026-08-13 | $1.57 | $273,461,500 | 2 / 2 |
| 2026-08-14 | $0.96 | $273,450,000 | 1 / 1 |
| 2026-08-15 | $0.96 | $273,450,000 | 1 / 1 |
| 2026-08-16 | $0.96 | $273,450,000 | 1 / 1 |
| 2026-08-17 | $0.96 | $273,450,000 | 1 / 1 |
| 2026-08-18 | $0.96 | $273,450,000 | 1 / 1 |
| 2026-08-19 | $0.96 | $273,450,000 | 1 / 1 |
| 2026-08-20 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-08-21 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-08-22 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-08-23 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-08-24 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-08-25 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-08-26 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-08-27 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-08-28 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-08-29 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-08-30 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-08-31 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-01 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-02 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-03 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-04 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-05 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-06 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-07 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-08 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-09 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-10 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-11 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-12 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-13 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-14 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-15 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-16 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-17 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-18 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-19 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-20 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-21 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-22 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-23 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-24 | $1.58 | $298,656,500 | 1 / 1 |
| 2026-09-25 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-09-26 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-09-27 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-09-28 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-09-29 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-09-30 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-01 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-02 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-03 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-04 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-05 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-06 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-07 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-08 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-09 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-10 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-11 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-12 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-13 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-14 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-15 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-16 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-17 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-18 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-19 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-20 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-21 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-22 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-23 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-24 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-25 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-26 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-27 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-28 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-29 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-30 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-10-31 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-11-01 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-11-02 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-11-03 | $1.58 | $298,676,500 | 1 / 1 |
| 2026-11-04 | $1.58 | $298,676,500 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.